Hou J, Lau G K, Cheng J, Cheng C C, Luo K, Carman W F
Department of Infectious Disease, Nanfang Hospital, The First Medical College of PLA, Guangzhou, China.
Liver. 1999 Oct;19(5):411-7. doi: 10.1111/j.1478-3231.1999.tb00070.x.
A double variant in the basal core promoter, converting nucleotide 1762 from A to T (T1762) and nucleotide 1764 from G to A (A[764), has been described in patients with chronic hepatitis B infection. Its prevalence and significance in Chinese chronic HBV carriers are unknown.
We studied 177 Chinese patients with chronic HBV infection (chronic hepatitis/asymptomatic: 89/88; hepatitis B e antigen positive/negative: 84/93). The double variant was detected by mismatched polymerase chain reaction and restriction fragment length polymorphism analysis. The reliability of this method was verified by sequencing in 41 serum samples with 100% matching.
The double variant T1762/ A1764 was found in 52 of 89 patients with chronic hepatitis, but in only 6 of 59 asymptomatic carriers (p<0.001). The prevalence was significantly lower in hepatitis B e antigen positive patients (23/84) than in hepatitis B e antigen negative patients (35/64) (p<0.005). Precore variant, A1896 was detected in 40 individuals; 31 of them suffered from chronic hepatitis and 9 were asymptomatic (p<0.001). A combination of both variants T1762/A1764 and A1896 was seen in 3 of 59 asymptomatic and 22 of 89 patients with chronic hepatitis (p<0.005).
Mismatched polymerase chain reaction with restriction fragment length polymorphism provides a reliable, easy and fast method for detection of the presence of the T1762/A1764 variant. In Chinese chronic hepatitis B carriers, T1762/A1764 variant was associated with both active liver disease and hepatitis B e antigen negativity.
在慢性乙型肝炎感染患者中已发现基础核心启动子存在双重变异,即核苷酸1762由A转换为T(T1762)以及核苷酸1764由G转换为A(A1764)。其在中国慢性乙肝携带者中的患病率及意义尚不清楚。
我们研究了177例中国慢性乙肝感染患者(慢性肝炎/无症状携带者:89/88;乙肝e抗原阳性/阴性:84/93)。通过错配聚合酶链反应和限制性片段长度多态性分析检测该双重变异。在41份血清样本中通过测序验证了该方法的可靠性,匹配率为100%。
89例慢性肝炎患者中有52例发现双重变异T1762/A1764,但59例无症状携带者中仅6例出现(p<0.001)。乙肝e抗原阳性患者中的患病率(23/84)显著低于乙肝e抗原阴性患者(35/64)(p<0.005)。在40例个体中检测到前核心变异A1896;其中31例患有慢性肝炎,9例无症状(p<0.001)。59例无症状患者中有3例以及89例慢性肝炎患者中有22例同时出现T1762/A1764和A1896两种变异(p<0.005)。
错配聚合酶链反应与限制性片段长度多态性分析为检测T1762/A1764变异的存在提供了一种可靠、简便且快速的方法。在中国慢性乙肝携带者中,T1762/A1764变异与活动性肝病及乙肝e抗原阴性均相关。